BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12819803)

  • 1. The impact of new technologies on drug design.
    Norman P
    Drug News Perspect; 2001 Mar; 14(2):123-8. PubMed ID: 12819803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Bioinformatics in Identifying and Defining Potential Drug Targets.
    Norman P
    Drug News Perspect; 2002 May; 15(4):253-256. PubMed ID: 12677210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New drug targets in inflammation and immunomodulation.
    Norman P
    Drug News Perspect; 1998 Sep; 11(7):442-7. PubMed ID: 15616686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicinal Chemistry--XVth EFMC International Symposium. New technologies in drug discovery. 6-10 September 1998, Edinburgh, Scotland, UK.
    Buckle DR
    IDrugs; 1998 Dec; 1(8):860-2. PubMed ID: 16196472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural Products as a Source of New Drugs.
    Norman P
    Drug News Perspect; 2002 Sep; 15(7):461-465. PubMed ID: 12677183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From virtuality to reality - Virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective.
    Rester U
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):559-68. PubMed ID: 18600572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design of molecular cancer therapeutics.
    van Montfort RL; Workman P
    Trends Biotechnol; 2009 May; 27(5):315-28. PubMed ID: 19339067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual screening in lead discovery and optimization.
    Jain AN
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):396-403. PubMed ID: 15338948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 7 TM G-protein-coupled receptor target family.
    Jacoby E; Bouhelal R; Gerspacher M; Seuwen K
    ChemMedChem; 2006 Aug; 1(8):761-82. PubMed ID: 16902930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel technologies for virtual screening.
    Lengauer T; Lemmen C; Rarey M; Zimmermann M
    Drug Discov Today; 2004 Jan; 9(1):27-34. PubMed ID: 14761803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicinal Chemistry in eastern England--tenth symposium. 22 April 1999, University of Hertfordshire, Hatfield, UK.
    Norman P
    IDrugs; 1999 Jul; 2(7):659-63. PubMed ID: 16127635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based drug design of new leads for phosphatase research.
    Combs AP
    IDrugs; 2007 Feb; 10(2):112-5. PubMed ID: 17285463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application and limitations of X-ray crystallographic data in structure-based ligand and drug design.
    Davis AM; Teague SJ; Kleywegt GJ
    Angew Chem Int Ed Engl; 2003 Jun; 42(24):2718-36. PubMed ID: 12820253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease Inhibition: Design, Technology & Opportunities--First RSC/SCI Symposium on Protease Inhibition.18-19 May 1998, London, UK.
    Buckle DR
    IDrugs; 1998 Jun; 1(2):185-8. PubMed ID: 18465527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual screening strategies in drug discovery.
    McInnes C
    Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated in silico tools for exploiting the natural products' bioactivity.
    Rollinger JM; Langer T; Stuppner H
    Planta Med; 2006 Jun; 72(8):671-8. PubMed ID: 16783689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A watershed of new knowledge in biomedical sciences.
    Boyd B
    Drug News Perspect; 2001 May; 14(4):248-56. PubMed ID: 12819796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.